Company Monitoring Page for JNJ

job ratings for JNJ

11/16/23
industry:
Big Pharma
company:
JNJ
job rating:
6
Boss is supportive and gives FTO
12/06/18
industry:
Medical Device
job title:
Staff engineer
company:
JNJ
job rating:
3
Compliance rules make no sense, no pragmatism, rules other commintment in multiple policy. Creating gap and auto-feeding compliant and audit department. It is like if there is not pilot in the plane.
07/25/18
industry:
Medical Device
company:
JNJ
job rating:
1
over worked and under paid

latest headlines for company on cafepharma

‘We think in decades’: J&J’s $30B spending spree may not be over
Medtech Dive
Tue, 04/16/24 - 10:07 pm
Tags:
JNJ, Medtech, M&A, Abiomed, Laminar, Shockwave Medical
J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales
BioSpace
Tue, 04/16/24 - 11:19 am
Tags:
JNJ, earnings
Q&A: Legend Biotech CEO on whether Carvykti can meet expectations
Medical Marketing and Media
Mon, 04/15/24 - 11:16 am
Tags:
Legend Biotech, Carvykti, mutliple myeloma, JNJ
J&J, Rallybio partner on drug development for rare fetal condition
BioPharma Dive
Wed, 04/10/24 - 06:01 pm
Tags:
JNJ, Rallybio, FNAIT, drug development
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
Tags:
oncology, M&A, AbbVie, Immunogen, Bristol Myers Squibb, Mirati Therapeutics, RayzeBio, Novartis, MorphoSys, AstraZeneca, Fusion Pharmaceuticals, JNJ, Ambrx, Gracell
J&J scoops up cardio medtech Shockwave Medical for $13.1B
Medical Marketing and Media
Fri, 04/5/24 - 11:54 am
Tags:
JNJ, M&A, Medtech, Shockwave Medical, Cardiovascular, intravascular lithotripsy
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
Tags:
biotech, M&A, IPOs, CG Oncology, Kyverna Therapeutics, Contineum Therapeutics, Boundless Bio, CymaBay Therapeutics, Gilead Sciences, MorphoSys, Novartis, Fusion Pharmaceuticals, AstraZeneca, Ambryx, JNJ, Inhibrix, Aventis
J&J targets rare maternal-fetal diseases: 'We're going for this. No one else has.'
Fierce Biotech
Tue, 04/2/24 - 11:49 am
Tags:
JNJ, rare disease, maternal-fetal diseases, FNAIT, nipocalimab
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
Reuters
Mon, 04/1/24 - 12:04 pm
Tags:
Teva Pharmaceutical, JNJ, Viatris, schizophrenia, patents, Invega Sustenna
J&J can contest evidence linking its talc to cancer, US judge rules
Reuters
Thu, 03/28/24 - 11:14 am
Tags:
JNJ, legal, talc, ovarian cancer
J&J Wins FDA Nod for Pulmonary Arterial Hypertension Combo Pill
BioSpace
Mon, 03/25/24 - 11:24 am
Tags:
JNJ, FDA, PAH, Opsynvi, macitentan, tadalafil
J&J's Abiomed sees serious Impella recall linked to heart perforations, 49 deaths
Fierce Biotech
Fri, 03/22/24 - 10:54 am
Tags:
JNJ, Abiomed, Medtech, Impella, patient deaths, device recalls
Idorsia's Tryvio crosses FDA finish line, offering new mechanism to treat hypertension
Fierce Pharma
Wed, 03/20/24 - 09:49 pm
Tags:
JNJ, Idorsia, Tryvio, hypertension, FDA
J&J alleges ex-staffer downloaded thousands of files in move to Pfizer
Seeking Alpha
Wed, 03/20/24 - 11:48 am
Tags:
JNJ, Pfizer, legal, trade secrets
Despite early death concerns, FDA advisers back J&J and Legend's Carvykti and BMS' Abecma for earlier myeloma
Fierce Pharma
Sun, 03/17/24 - 09:30 pm
Tags:
JNJ, Legend Biotech, CAR-T, FDA, Carvykti, Abecma
Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer
BioSpace
Sun, 03/17/24 - 09:25 pm
Tags:
Asgard Therapeutics, JNJ, Novo Nordisk, Boehringer Ingelheim, funding, immuno-oncology
BMS’s Breyanzi Becomes First CAR-T Therapy for Two Types of Leukemia
BioSpace
Fri, 03/15/24 - 11:32 am
Tags:
Bristol Myers Squibb, CAR-T, CLL, Breyanzi, FDA, JNJ, Carvykti
J&J, Novo support Asgard’s push to make ‘in vivo’ cell therapies
BioPharma Dive
Thu, 03/14/24 - 11:31 am
Tags:
Asgard Therapeutics, in vivo cell therapy, cell therapy, JNJ, Novo Nordisk
J&J's Duato nets major raise to $28.4M, jumps to top of pharma CEO pay rankings
Fierce Pharma
Wed, 03/13/24 - 10:26 pm
Tags:
JNJ, Joaquin Duato, executive pay, Pharma CEOs
FDA staff raises concerns over data from J&J, Bristol's CAR-T therapies
Reuters
Wed, 03/13/24 - 10:46 am
Tags:
FDA, JNJ, Bristol Myers Squibb, blood cancers, cell therapy

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.